GABA
| Names | |
|---|---|
| Pronunciation | /ˈɡæmə əˈmiːnoʊbjuːˈtɪrɪk ˈæsɪd/, /ˈɡæbə/ (GABA) |
| Preferred IUPAC name
4-Aminobutanoic acid | |
Other names
| |
| Identifiers | |
3D model (JSmol) |
|
| 906818 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.000.235 |
| EC Number |
|
| 49775 | |
| KEGG | |
| MeSH | gamma-Aminobutyric+Acid |
PubChem CID |
|
| RTECS number |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C4H9NO2 | |
| Molar mass | 103.121 g·mol−1 |
| Appearance | white microcrystalline powder |
| Density | 1.11 g/mL |
| Melting point | 203.7 °C (398.7 °F; 476.8 K) |
| Boiling point | 247.9 °C (478.2 °F; 521.0 K) |
| 1.2 [ug/mL] | |
| log P | −3.17 |
| Acidity (pKa) |
|
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards |
Irritant, Harmful |
| Lethal dose or concentration (LD, LC): | |
LD50 (median dose) |
12,680 mg/kg (mouse, oral) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
GABA (gamma-aminobutyric acid, γ-aminobutyric acid) is the chief inhibitory neurotransmitter in the developmentally mature mammalian central nervous system. Its principal role is reducing neuronal excitability throughout the nervous system.
GABA is sold as a dietary supplement in many countries. It has been traditionally thought that exogenous GABA (i.e., taken as a supplement) does not cross the blood–brain barrier, but data obtained from more recent research (2010s) in rats describes the notion as being unclear.
The carboxylate form of GABA is γ-aminobutyrate.